Logo image of CBK.DE

COMMERZBANK AG (CBK.DE) Stock Fundamental Analysis

FRA:CBK - Deutsche Boerse Ag - DE000CBK1001 - Common Stock - Currency: EUR

28.3  -0.59 (-2.04%)

Fundamental Rating

2

Overall CBK gets a fundamental rating of 2 out of 10. We evaluated CBK against 91 industry peers in the Banks industry. CBK may be in some trouble as it scores bad on both profitability and health. CBK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CBK was profitable.
In the past year CBK has reported a negative cash flow from operations.
Of the past 5 years CBK 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: CBK reported negative operating cash flow in multiple years.
CBK.DE Yearly Net Income VS EBIT VS OCF VS FCFCBK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B -20B 30B

1.2 Ratios

With a Return On Assets value of 0.44%, CBK is not doing good in the industry: 70.79% of the companies in the same industry are doing better.
CBK has a worse Return On Equity (7.15%) than 65.17% of its industry peers.
Industry RankSector Rank
ROA 0.44%
ROE 7.15%
ROIC N/A
ROA(3y)0.37%
ROA(5y)0.12%
ROE(3y)5.88%
ROE(5y)1.6%
ROIC(3y)N/A
ROIC(5y)N/A
CBK.DE Yearly ROA, ROE, ROICCBK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

CBK has a Profit Margin (19.01%) which is in line with its industry peers.
CBK's Profit Margin has improved in the last couple of years.
CBK does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 19.01%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y87.93%
PM growth 5Y25.01%
GM growth 3YN/A
GM growth 5YN/A
CBK.DE Yearly Profit, Operating, Gross MarginsCBK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1

2. Health

2.1 Basic Checks

CBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CBK has less shares outstanding
CBK has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CBK is higher compared to a year ago.
CBK.DE Yearly Shares OutstandingCBK.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CBK.DE Yearly Total Debt VS Total AssetsCBK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B 500B

2.2 Solvency

CBK has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
CBK has a Debt to Equity ratio of 1.59. This is in the better half of the industry: CBK outperforms 64.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC13.51%
CBK.DE Yearly LT Debt VS Equity VS FCFCBK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBK.DE Yearly Current Assets VS Current LiabilitesCBK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.96% over the past year.
The Earnings Per Share has been growing by 28.05% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 3.72% in the past year.
The Revenue has been growing slightly by 6.65% on average over the past years.
EPS 1Y (TTM)15.96%
EPS 3Y103.28%
EPS 5Y28.05%
EPS Q2Q%25.81%
Revenue 1Y (TTM)3.72%
Revenue growth 3Y8.47%
Revenue growth 5Y6.65%
Sales Q2Q%7.35%

3.2 Future

The Earnings Per Share is expected to grow by 7.25% on average over the next years.
The Revenue is expected to grow by 3.52% on average over the next years.
EPS Next Y6.3%
EPS Next 2Y17.71%
EPS Next 3Y18.63%
EPS Next 5Y7.25%
Revenue Next Year8.03%
Revenue Next 2Y7.51%
Revenue Next 3Y6.94%
Revenue Next 5Y3.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CBK.DE Yearly Revenue VS EstimatesCBK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
CBK.DE Yearly EPS VS EstimatesCBK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.52 indicates a correct valuation of CBK.
77.53% of the companies in the same industry are cheaper than CBK, based on the Price/Earnings ratio.
CBK is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 9.73 indicates a reasonable valuation of CBK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBK is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CBK to the average of the S&P500 Index (35.19), we can say CBK is valued rather cheaply.
Industry RankSector Rank
PE 12.52
Fwd PE 9.73
CBK.DE Price Earnings VS Forward Price EarningsCBK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBK.DE Per share dataCBK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CBK's earnings are expected to grow with 18.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.99
PEG (5Y)0.45
EPS Next 2Y17.71%
EPS Next 3Y18.63%

4

5. Dividend

5.1 Amount

CBK has a Yearly Dividend Yield of 2.25%. Purely for dividend investing, there may be better candidates out there.
With a Dividend Yield of 2.25, CBK pays less dividend than the industry average, which is at 5.19. 89.89% of the companies listed in the same industry pay a better dividend than CBK!
CBK's Dividend Yield is comparable with the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 2.25%

5.2 History

On average, the dividend of CBK grows each year by 11.38%, which is quite nice.
Dividend Growth(5Y)11.38%
Div Incr Years1
Div Non Decr Years2
CBK.DE Yearly Dividends per shareCBK.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

16.84% of the earnings are spent on dividend by CBK. This is a low number and sustainable payout ratio.
The dividend of CBK is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP16.84%
EPS Next 2Y17.71%
EPS Next 3Y18.63%
CBK.DE Yearly Income VS Free CF VS DividendCBK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B -20B 30B
CBK.DE Dividend Payout.CBK.DE Dividend Payout, showing the Payout Ratio.CBK.DE Dividend Payout.PayoutRetained Earnings

COMMERZBANK AG

FRA:CBK (7/11/2025, 7:00:00 PM)

28.3

-0.59 (-2.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners41.92%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap33.53B
Analysts78.18
Price Target27.32 (-3.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.25%
Yearly Dividend0.34
Dividend Growth(5Y)11.38%
DP16.84%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.62%
Min EPS beat(2)32.01%
Max EPS beat(2)83.22%
EPS beat(4)3
Avg EPS beat(4)22.65%
Min EPS beat(4)-35.08%
Max EPS beat(4)83.22%
EPS beat(8)6
Avg EPS beat(8)19.12%
EPS beat(12)8
Avg EPS beat(12)16.16%
EPS beat(16)11
Avg EPS beat(16)55.67%
Revenue beat(2)2
Avg Revenue beat(2)1.84%
Min Revenue beat(2)1.03%
Max Revenue beat(2)2.64%
Revenue beat(4)3
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-1.15%
Max Revenue beat(4)2.64%
Revenue beat(8)6
Avg Revenue beat(8)23.86%
Revenue beat(12)10
Avg Revenue beat(12)25.44%
Revenue beat(16)14
Avg Revenue beat(16)22.89%
PT rev (1m)0%
PT rev (3m)13.94%
EPS NQ rev (1m)3.59%
EPS NQ rev (3m)-2.99%
EPS NY rev (1m)0%
EPS NY rev (3m)0.37%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.85%
Valuation
Industry RankSector Rank
PE 12.52
Fwd PE 9.73
P/S 2.59
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 1.03
EV/EBITDA N/A
EPS(TTM)2.26
EY7.99%
EPS(NY)2.91
Fwd EY10.28%
FCF(TTM)-18.12
FCFYN/A
OCF(TTM)-17.15
OCFYN/A
SpS10.94
BVpS29.09
TBVpS27.59
PEG (NY)1.99
PEG (5Y)0.45
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 7.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 19.01%
GM N/A
FCFM N/A
ROA(3y)0.37%
ROA(5y)0.12%
ROE(3y)5.88%
ROE(5y)1.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y87.93%
PM growth 5Y25.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.16%
Cap/Sales 8.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC13.51%
ROIC/WACCN/A
Cap/Depr(3y)98.87%
Cap/Depr(5y)65.9%
Cap/Sales(3y)7.2%
Cap/Sales(5y)8.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.96%
EPS 3Y103.28%
EPS 5Y28.05%
EPS Q2Q%25.81%
EPS Next Y6.3%
EPS Next 2Y17.71%
EPS Next 3Y18.63%
EPS Next 5Y7.25%
Revenue 1Y (TTM)3.72%
Revenue growth 3Y8.47%
Revenue growth 5Y6.65%
Sales Q2Q%7.35%
Revenue Next Year8.03%
Revenue Next 2Y7.51%
Revenue Next 3Y6.94%
Revenue Next 5Y3.52%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-211.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-200.16%
OCF growth 3YN/A
OCF growth 5YN/A